These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7751898)

  • 1. Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors.
    Lee JS; Newman RA; Lippman SM; Fossella FV; Calayag M; Raber MN; Krakoff IH; Hong WK
    J Clin Oncol; 1995 Jun; 13(6):1501-8. PubMed ID: 7751898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole.
    Rigas JR; Francis PA; Muindi JR; Kris MG; Huselton C; DeGrazia F; Orazem JP; Young CW; Warrell RP
    J Natl Cancer Inst; 1993 Dec; 85(23):1921-6. PubMed ID: 8230282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.
    Lee JS; Newman RA; Lippman SM; Huber MH; Minor T; Raber MN; Krakoff IH; Hong WK
    J Clin Oncol; 1993 May; 11(5):959-66. PubMed ID: 8487058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
    Muindi JR; Frankel SR; Huselton C; DeGrazia F; Garland WA; Young CW; Warrell RP
    Cancer Res; 1992 Apr; 52(8):2138-42. PubMed ID: 1559217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
    Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in the oral bioavailability of all-trans-retinoic acid.
    Adamson PC; Pitot HC; Balis FM; Rubin J; Murphy RF; Poplack DG
    J Natl Cancer Inst; 1993 Jun; 85(12):993-6. PubMed ID: 8388479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats.
    Van Wauwe JP; Coene MC; Goossens J; Cools W; Monbaliu J
    J Pharmacol Exp Ther; 1990 Jan; 252(1):365-9. PubMed ID: 2299598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid.
    Van Wauwe JP; Coene MC; Goossens J; Van Nijen G; Cools W; Lauwers W
    J Pharmacol Exp Ther; 1988 May; 245(2):718-22. PubMed ID: 3367313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of all-trans retinoic acid.
    Muindi JR; Young CW; Warrell RP
    Leukemia; 1994; 8 Suppl 3():S16-21. PubMed ID: 7808019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans-retinoic acid in patients with advanced cancer.
    Muindi JF; Scher HI; Rigas JR; Warrell RP; Young CW
    Cancer Res; 1994 Apr; 54(8):2125-8. PubMed ID: 8174117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cytochrome P450 inhibitors (diethyl dithiocarbamate, ketoconazole and grapefruit juice) on the pharmacokinetics of all-trans-retinoic acid.
    Saadeddin A; Torres-Molina F; Cárcel-Trullols J; Araico A; Peris JE
    Farmaco; 2004 Sep; 59(9):697-702. PubMed ID: 15337435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
    Rizvi NA; Marshall JL; Ness E; Yoe J; Gill GM; Truglia JA; Loewen GR; Jaunakais D; Ulm EH; Hawkins MJ
    Clin Cancer Res; 1998 Jun; 4(6):1437-42. PubMed ID: 9626460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of all-trans retinoic acid pharmacokinetics by liarozole.
    Miller VA; Rigas JR; Muindi JR; Tong WP; Venkatraman E; Kris MG; Warrell RP
    Cancer Chemother Pharmacol; 1994; 34(6):522-6. PubMed ID: 7923564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
    Achkar CC; Bentel JM; Boylan JF; Scher HI; Gudas LJ; Miller WH
    Drug Metab Dispos; 1994; 22(3):451-8. PubMed ID: 8070324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of all-trans retinoic acid.
    Muindi JR; Young CW; Warrell RP
    Leukemia; 1994 Nov; 8(11):1807-12. PubMed ID: 7967726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.
    Smith MA; Adamson PC; Balis FM; Feusner J; Aronson L; Murphy RF; Horowitz ME; Reaman G; Hammond GD; Fenton RM
    J Clin Oncol; 1992 Nov; 10(11):1666-73. PubMed ID: 1403049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel.
    Sarantopoulos J; Mita AC; Wade JL; Morris JC; Rixe O; Mita MM; Dedieu JF; Wack C; Kassalow L; Lockhart AC
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1113-24. PubMed ID: 25307552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein.
    Adamson PC; Boylan JF; Balis FM; Murphy RF; Godwin KA; Gudas LJ; Poplack DG
    Cancer Res; 1993 Feb; 53(3):472-6. PubMed ID: 8381046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A.
    Schmitt-Hoffmann AH; Roos B; Sauer J; Spickermann J; Maares J; Schoetzau A; Meyer I
    Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():24-8. PubMed ID: 21443601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 2-(4-aminophenylmethyl)-6-hydroxy-3, 4-dihydronaphthalen-1(2H)-one on all-trans and 13-cis-retinoic acid levels in plasma quantified by high perfomance liquid chromatography coupled to tandem mass spectrometry.
    Angotti M; Hartmann RW; Kirby AJ; Simons C; Nicholls PJ; Sewell RD; Smith HJ
    J Enzyme Inhib Med Chem; 2005 Jun; 20(3):219-26. PubMed ID: 16119191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.